This is a working overview of lyophilized powder, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-09-26. Anything still debated is marked as such rather than presented as settled.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 4963 Da for full-length thymosin beta-4 | Value applies to the parent protein; fragment products may differ |
| Appearance | White to off-white lyophilized powder | Typical form of supplied synthetic peptide |
| Solubility | Freely soluble in water | Polar peptide; dissolves readily in aqueous buffer |
| Storage of dry powder | −20 °C, desiccated, protected from light | Standard laboratory practice for peptides |
| Typical detection method | Liquid chromatography–tandem mass spectrometry | Used in purity testing and anti-doping analysis |
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
Research interest in thymosin beta-4 fragments centres on actin sequestration, cell migration and tissue repair models. Most published work uses cultured cells or animal wound and cardiac preparations, and findings are generally described as preliminary. No fragment of this protein has been approved as a therapeutic product by major regulators. Reviews of the field note inconsistent dosing, delivery routes and outcome measures across studies, which complicates direct comparison. The material is best understood as a laboratory reagent with an active but unresolved research literature.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
== Medical uses == The chikungunya vaccine is indicated for the prevention of disease caused by chikungunya virus. In the European Union, use of the live attenuated vaccine (Ixchiq) has been restricted to individuals with a high risk of becoming infected with the chikungunya virus. This restriction is due to safety concerns resulting from side effects of the vaccince.
In addition, San Martín came to be accused of falling into a serious anti-Peruvian hypocrisy with the monarchical project of the Protectorate of San Martín, by preferring the coming of European princes (betraying several nationalist Peruvians), leaving aside the already existing and millennial institutions national monarchists in Peru to imitate the parliamentary constitutionalism of the English and French in the restoration (being accused of being Anglophile and Frenchified by Peruvian Hispanicism), as well as having little or no consideration for monarchical proposals that represented the interests of the indigenous nobility (being accused of Criollo elitist by the Peruvian indigenism). For example, the case of the indigenous nobility of the Cajamarca region, which, after obtaining knowledge of the sworn independence on January 8, 1821, by Torre Tagle (despite the exclusion of indigenous representatives from the Cabildo de Naturales and famous curacas in rural populations, such as Manuel Anselmo Carhuaguatay), he tried to introduce himself and propose that the form of government of the new Peruvian state should correspond to a descendant of Atahualpa who lived in the town, the most notorious being Don Manuel Soto Astopilco (main cacique of the Seven Huarangas of the province), in addition to suggesting the rebirth of the State of Tahuantinsuyo and its right to the crown. No news was recorded that he tried to invoke possible links with the distant and exhausted Incas of Cusco (mostly more favorable to the Royal Army of Peru).
The Scar Free Foundation is a medical research charity focused on scar free healing. It was founded in 1998 by plastic surgeon Michael Brough, following his work with survivors of the King's Cross Fire in London. Initially known as The Healing Foundation, it was relaunched as The Scar Free Foundation in 2016. The charity funds medical research into wound healing and scarring conditions. Current research is focused on identifying the pathways that lead to scarring, developing new treatment options, and improving the psychological outcomes and quality of life of patients currently living with scars. The current Chairman is former Medical Director of the NHS, Sir Bruce Keogh, and the Chief Executive is Richard Nugee CB CVO CBE. Peter Weissberg CBE is the Research Council Chairman. Sophie, Duchess of Edinburgh is the charity's Royal Patron. Notable Ambassadors include Simon Weston CBE and Pam Warren.
=== Disassociation === Ensuring that every specimen has an individual accession number will reduce the risk of disassociation. The accession number relates that number to an identifiable object and the object can only be moved if its location is updated, ensuring the object is never disassociated from its data. Most herbaria utilize a standard system of organizing their specimens into herbarium cases. Specimen sheets are stacked in groups by the species to which they belong and placed into a large lightweight folder that is labeled on the bottom edge. Groups of species folders are then placed together into larger folders by genus. The genus folders are then sorted by taxonomic family according to the standard system selected for use by the herbarium and placed into pigeonholes in herbarium cabinets. Locating a specimen filed in the herbarium requires knowing the nomenclature and classification used by the herbarium. It also requires familiarity with possible name changes that have occurred since the specimen was collected, since the specimen may be filed under an older name. Modern herbaria often maintain electronic databases of their collections. Many herbaria have initiatives to digitize specimens to produce a virtual herbarium. These records and images are made publicly accessible via the Internet when possible.
The imprinted image turned out to be wash-resistant, impervious to temperatures of 250 °C (482 °F) and was undamaged by exposure to a range of harsh chemicals, including bisulphite, which, without the gelatine, would normally have degraded ferric oxide to the compound ferrous oxide. Instead of painting, it has been suggested that the bas-relief could also be heated and used to scorch an image onto the cloth. However researcher Thibault Heimburger performed some experiments with the scorching of linen, and found that a scorch mark is only produced by direct contact with the hot object—thus producing an all-or-nothing discoloration with no graduation of color as is found in the shroud.
Sources: en.wikipedia.org
Nuclear warfare and weapons are staple elements of speculative fiction. The War Game by Peter Watkins is a docudrama depicting a hypothetical nuclear attack on Britain. Fail Safe, directed by Sidney Lumet, is a 1964 Cold War techno-thriller presenting a dramatization of an unintended nuclear escalation triggered by a mechanical failure.
== Patents == Compositions and methods for inducing apoptosis. J. Kopeček, J. Yang, T.-W. Chu. (2019) US 10,251,906 B2. Compositions and methods for using albumin-based nanomedicines. J. Kopeček, J. Yang. US 10,925,973 (Feb. 23, 2021) Polymeric drug delivery conjugates and methods of making and using thereof. H. Pan, J. Yang, P. Kopečková, K. Luo, J. Kopeček (2016) US 9,289,510 B2 Hydrogels of water-soluble polymers crosslinked by protein domains. J. Kopeček, R. Stewart, K. Caldwell, C. Wang, C-H. Ho (2007) US 7,179,487 Synthetic polymeric drugs. J. Kopeček, P. Rejmanová, J. Strohalm, K. Ulbrich, B. Říhová, V. Chytrý, J.B. Lloyd, R. Duncan (1991) US 5,037,883 Copolymers based on N-substituted acrylamides, N-substituted methacrylamides and N,N-disubstituted acrylamides and the method of their manufacturing. J. Kopeček, K. Ulbrich, J. Vacík, J. Strohalm, V. Chytrý, J. Drobník, J. Kálal (1977) US 4,062,831 Device for connecting or joining the ends of interrupted tubular organs in surgical operations without stitching. D. Lím, L. Šprincl, J. Kopeček (1973) US 3,774,615 Increasing permeability of reverse osmosis membranes. J. Kopeček, S. Sourirajan (1970) US 3,536,612
Sub-slab depressurization (soil suction) by increasing under-floor ventilation; Improving the ventilation of the house and avoiding the transport of radon from the basement into living rooms; Installing a radon sump system in the basement; Installing a positive pressurization or positive supply ventilation system. According to the EPA, the method to reduce radon "...primarily used is a vent pipe system and fan, which pulls radon from beneath the house and vents it to the outside", which is also called sub-slab depressurization, active soil depressurization, or soil suction. Generally indoor radon can be mitigated by sub-slab depressurization and exhausting such radon-laden air to the outdoors, away from windows and other building openings. "[The] EPA generally recommends methods which prevent the entry of radon. Soil suction, for example, prevents radon from entering your home by drawing the radon from below the home and venting it through a pipe, or pipes, to the air above the home where it is quickly diluted" and the "EPA does not recommend the use of sealing alone to reduce radon because, by itself, sealing has not been shown to lower radon levels significantly or consistently". Positive-pressure ventilation systems can be combined with a heat exchanger to recover energy in the process of exchanging air with the outside, and simply exhausting basement air to the outside is not necessarily a viable solution as this can actually draw radon gas into a dwelling.
==== Role in cardiac hypertrophy and fibrosis ==== Intracrine Ang II has been implicated in the development of cardiac hypertrophy, a process characterized by the enlargement of cardiac myocytes in response to increased workload or stress. Experimental models have shown that overexpression of non-secreted Ang II in cardiac cells leads to rapid hypertrophy independent of extracellular Ang II signaling. This suggests that intracellular Ang II plays a direct role in cardiomyocyte growth and structural remodeling. Similarly, intracrine Ang II contributes to myocardial fibrosis by upregulating profibrotic cytokines and growth factors, such as transforming growth factor-beta (TGF-β) and platelet-derived growth factor (PDGF). This promotes the excessive deposition of extracellular matrix proteins, leading to stiffening of the cardiac tissue and impaired cardiac function.
=== Diet === People with autoimmune hyperthyroidism (such as in Graves' disease) should not eat foods high in iodine, such as edible seaweed and seafood. From a public health perspective, the general introduction of iodized salt in the United States in 1924 resulted in lower rates of disease and goiters, and improved the lives of children whose mothers would not have eaten enough iodine during pregnancy, which would have lowered the IQs of their children.
Sources: en.wikipedia.org
Internal coenzyme/cofactor photocatalyst External photocatalyst Certain common hydrogen atom transfer (HAT) cofactors (NADPH and Flavin) can operate as single electron transfer (SET) reagents. Although these species are capable of HAT without irradiation, their redox potentials are enhance by nearly 2.0 V upon visible light irradiation. When paired with their respective enzymes (typically ene-reductases) This phenomenon has been utilized by chemists to develop enantioselective reduction methodologies. For example medium sized lactams can be synthesized in the chiral environment of an ene-reductase through a reductive, baldwin favored, radical cyclization terminated by enantioselective HAT from NADPH. The second category of photoredox enabled biocatalytic reactions use an external photocatalyst (PC). Many types of PCs with a large range of redox potentials can be utilized, allowing for greater tunability of reactive compared to using a cofactor. Rose bengal, and external PC, was utilized in tandem with an oxidoreductase to enantioselectively deacylate medium sized alpha-acyl-ketones. Using an external PC has some downsides. For example, external PCs typically complicate reaction design because the PC may react with both the bound and unbound substrate. If a reaction occurs between the unbound substrate and the PC, enantioselectivity is lost and other side reactions may occur.
==== Officer of the Order of the British Empire (OBE) ==== Military Division Royal Navy Commander Peter David Ambrose. Commander Charles Anthony Johnstone-Burt. Major Stephen John Duyland Bush, Royal Marines. Commander Michael John Channon. Commander Brian Paul Boxall-Hunt. Commander George McAleese. Commander Peter John Linstead-Smith. Army Lieutenant Colonel Peter John Barrett (482686), Adjutant General's Corps (SPS). Lieutenant Colonel Brian McDonnell (509404), The Royal Anglian Regiment. Lieutenant Colonel George McGarr (508552), The Royal Logistic Corps. Lieutenant Colonel Brian Nutt (489575), Corps of Royal Electrical and Mechanical Engineers. Lieutenant Colonel Keith Henry Neville Prentice (488202), Royal Regiment of Artillery. Acting Colonel John David Reason (467319), Devonshire Army Cadet Force, Territorial Army. Lieutenant Colonel John David Sainsbury, , (453727), Royal Regiment of Artillery (Volunteers), Territorial Army. Lieutenant Colonel John Alexander Broome Salmon (486736), The Princess of Wales's Royal Regiment. Lieutenant Colonel John Alexander Thomson (496402) The Cheshire Regiment (Volunteers), Territorial Army. Lieutenant Colonel Philip Roy West (485857), Royal Regiment of Artillery. Royal Air Force Wing Commander Michael Carl Barter (8026633). Wing Commander Walter Simon Erskine Crum (0608265). Wing Commander Nigel Kenneth Gillingham (5203514). Wing Commander Malcolm Kenneth Hinder (0207878), Royal Air Force Volunteer Reserve (Training). Wing Commander Michael John Jones (0685361). Wing Commander Brian David Longman (0609376).
Larger doses do not appear to increase risks in this population. A broader retrospective study found that the rate of hyperkalemia in gender-diverse individuals is correlated with age, with those above 45 years old being more at risk. The finding suggests that patients below or at 45 years old without other conditions that affect potassium handling can be spared from routine monitoring.
==== Other uses in music ==== Adult Alternative Airplay, Triple A, or formerly, Adult Alternative Songs, a record chart published by Billboard Adult album alternative, a radio format AAA song form (AKA strophic form, verse-repeating form, chorus form, or one-part song form)
In March 1996, Haftar again briefly returned to Libya to instigate an uprising against Gaddafi in the mountains of eastern Libya. The Revolutionary Committees experienced a resurgence to combat these Islamists. In 1989, Gaddafi was overjoyed by the foundation of the Arab Maghreb Union, uniting Libya in an economic pact with Mauritania, Morocco, Tunisia, and Algeria, viewing it as beginnings of a new pan-Arab union. Gaddafi was able to recover some influence in Chad after Hissène Habré was overthrown by Idriss Déby in a Libya-sponsored coup in 1990. Déby also gave Gaddafi detailed information about CIA operations in Chad. Meanwhile, Libya stepped up its support for anti-Western militants such as the Provisional IRA, and in 1988, Pan Am Flight 103 was blown up over Lockerbie in Scotland, killing 243 passengers and 16 crew members, plus 11 people on the ground. British police investigations identified two Libyans – Abdelbaset al-Megrahi and Lamin Khalifah Fhimah – as the chief suspects, and in November 1991 issued a declaration demanding that Libya hand them over. When Gaddafi refused, citing the Montreal Convention, the United Nations (UN) imposed Resolution 748 in March 1992, initiating economic sanctions against Libya which had deep repercussions for the country's economy. The country suffered an estimated US$900 million financial loss as a result. On 5 November 1995, US President Bill Clinton declared the US would continue to induce pressure on Libya, also recognizing that Libyan terrorists were responsible for the Lockerbie bombing.
Sources: en.wikipedia.org
Not necessarily. TB-500 is a commercial label that suppliers apply to synthetic peptides described as thymosin beta-4 or a fragment of it. Published research most often studies the full-length protein, so statements about one do not automatically transfer to the other.
No. No major regulatory authority lists an approved product under this name, and no pharmacopoeial monograph exists for it. Material sold under the label is therefore supplied outside approved pharmaceutical channels, which affects the quality documentation available.
It falls within a prohibited class covering peptide hormones and growth factors, based on presumed effects on tissue repair and blood vessel formation. Anti-doping laboratories have published mass spectrometry methods for detecting thymosin beta-4 related peptides in urine samples.
Usually not, though usage overlaps. The label most often refers to a short acetylated fragment of the parent protein, while thymosin beta-4 itself is the full 43-residue molecule. Because suppliers vary, a sequence statement is needed to settle the question for any particular lot.